Table 2.

Relevant fibroblasts (CD90⁺/CD90⁻) involved in some diseases

Fibroblasts (CD90+/CD90−)	Disease name	References
CD90+	Rheumatoid arthritis	Mizoguchiet al. (2018), Varzideh et al. (2022), Kurose et al. (2022)
	Inflammatory arthritis	Wei et al. (2020), Onuora (2020)
	Inflammatory skin disease	Nazari et al. (2016), Barron et al. (2019)
	Pulmonary fibrosis	Pechkovsky et al. (2012), Zhang et al. (2019)
	Melanoma	Goldstein et al. (2005)
	Esophageal cancer	Krämer et al. (2020)
	Colorectal cancer	Tancharoen et al. (2017), Gao et al. (2022)
	Renal fibrosis	(Borza et al. 2022; Zheng et al. 2019)
	Prostatic cancer	Sauzay et al. (2019), Kwon et al. (2019)
	Pancreatic cancer	Ziani et al. (2018), Öhlund et al. (2014), Ding et al. (2018)
	Liver cancer	Zhao et al. (2016)
CD90−	Pulmonary fibrosis	Celada et al. (2018), Zhang et al. (2019), Yang et al. (2020)